| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01437943 Details | 2017-05-01 Interventional | 4 | 10 | Aliskiren Kidney Diseases Kidney Failure,… Renal Insuffici… Kidney Disease | Novartis has have decided to terminate all clinical investigator-initiated research projects
involving aliskiren In December 2011, all studies involving Aliskiren were terminated by Novartis after interim analysis of the ALTITUDE trial. | |||
| NCT00827281 Details | 2017-05-01 Interventional | 2 | 0 | Cycloserine Smokers | Study was not funded and pilot work proved impractical. - | |||
| NCT02840162 Details | 2017-04-28 Interventional | 2 | 34 | Celecoxib Prostatic Neopl… Adenocarcinoma … Prostate Cancer | Drug safety concerns - | |||
| NCT02371577 Details | 2017-04-28 Interventional | 2 | 0 | Lenalidomide Leukemia, Lymph… Chronic Lymphoc… | withdrawn - | |||
| NCT01913015 Details | 2017-04-28 Interventional | 1 | 3 | Abiraterone Ace… Prostatic Neopl… Adenocarcinoma … Hormone-resista… Recurrent Prost… Stage IV Prosta… | After enrollment of the first 3 subjects, an interim assessment was conducted. Comparing DBS
sampling to plasma PK levels yielded unconvincing results. - | |||
| NCT00796419 Details | 2017-04-28 Interventional | 3 | 31 | Hydroxyethyl St… Acute Lung Inju… Lung Injury Respiratory Dis… Respiratory Dis… Wounds and Inju… Lung Injury, Ac… Respiratory Dis… | - - | |||
| NCT00459810 Details | 2017-04-28 Interventional | 2 | 21 | Estradiol Paclitaxel Paclitaxel poli… Prostatic Neopl… Prostate Cancer | - - | |||
| NCT02511613 Details | 2017-04-27 Interventional | 2 | 0 | Ophthalmic Solu… Pharmaceutical … Ranibizumab Squalamine Macular Degener… Age-Related Mac… | Company decision - | |||
| NCT02447016 Details | 2017-04-27 Interventional | 4 | 25 | Efavirenz Emtricitabine Rilpivirine Tenofovir HIV | no more participants taking atripla - | |||
| NCT02060669 Details | 2017-04-27 Interventional | 3 | 10 | Capecitabine Colorectal Neop… Metastatic Colo… | others - | |||
| NCT00239720 Details | 2017-04-27 Interventional | 2 | 4 | Muromonab-CD3 Arthritis Arthritis, Psor… | Study team decision-impact(s) of change in hOKT3γ1 (Ala-Ala) manufacturer during study. This study was put on voluntary clinical hold after a serious adverse event occurred. After a review of the data, the team decided to close the study to further enrollment. Due to limited participants, no formal statistical analyses were performed | |||
| NCT03065933 Details | 2017-04-26 Interventional | 4 | 5 | Clonidine Bipolar Disorde… Bipolar Disorde… | - - | |||
| NCT02430532 2014-003021-18 Details | 2017-04-26 Interventional | 3 | 58 | Dimethyl Fumara… Multiple Sclero… Multiple Sclero… Neoplasm Metast… Sclerosis Multiple Sclero… | Sponsor Decision The study was terminated early by the sponsor for business reasons. Efficacy, patient-reported outcomes, and pharmacodynamic data were not analyzed. | |||
| NCT01171482 Details | 2017-04-26 Interventional | 2 | 5 | Fluorouracil Mitomycin Mitomycins Sorafenib Carcinoma Carcinoma, Hepa… | There were problems with national reimbursement policies. - | |||
| NCT00062972 Details | 2017-04-25 Interventional | 3 | 0 | Donepezil Multiple Sclero… Sclerosis | Study terminated/withdrawn - | |||
| NCT02567396 Details | 2017-04-24 Interventional | 1 | 0 | Talazoparib Breast Neoplasm… Carcinoma Carcinoma, Non-… Carcinoma, Ovar… Lung Neoplasms Mesothelioma Mesothelioma, M… Ovarian Neoplas… Small Cell Lung… Squamous Cell C… Stomach Neoplas… Estrogen Recept… HER2/Neu Negati… Head and Neck S… Hormone-Resista… Metastatic Panc… Progesterone Re… Solid Neoplasm Stage III Mesot… Stage IIIA Gast… Stage IIIA Non-… Stage IIIA Ovar… Stage IIIA Smal… Stage IIIB Gast… Stage IIIB Non-… Stage IIIB Ovar… Stage IIIB Smal… Stage IIIC Gast… Stage IIIC Ovar… Stage IV Mesoth… Stage IV Non-Sm… Stage IV Ovaria… Stage IV Small … Triple-Negative… | Other- Protocol moved to Disapproved - | |||
| NCT02542098 Details | 2017-04-24 Interventional | 2 | 0 | Hydrocodone Pain | Study has been updated with a new protocol number - | |||
| NCT01520025 Details | 2017-04-24 Interventional | 4 | 18 | Fluorodeoxygluc… Ischemia Myocardial Isch… | Continued recruitment of study participants was not feasible - | |||
| NCT01236508 Details | 2017-04-24 Interventional | 4 | - | Fluorodeoxygluc… Carotid Stenosi… Inflammation Leukoencephalop… Stroke Carotid Artery … TIA | difficulties recruiting this population for study population - | |||
| NCT00937417 Details | 2017-04-24 Interventional | 1 | 0 | Docetaxel Breast Neoplasm… Head and Neck N… Lung Neoplasms Prostatic Neopl… Breast Cancer Head and Neck C… Lung Cancer Prostate Cancer Unspecified Adu… | Withdrawn because SWOG no longer pursuing this study at this time - |